UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Tissue factor as a link between inflammation and coagulation

Trends in cardiovascular medicine, 2016-05, Vol.26 (4), p.297-303

2016

Link zum Volltext

Verfügbarkeit prüfen

Intestinal Microbiota in Cardiovascular Health and Disease

Journal of the American College of Cardiology, 2019-04, Vol.73 (16), p.2089-2105

2019

Link zum Volltext

Verfügbarkeit prüfen

Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives

European heart journal, 2018-08, Vol.39 (29), p.2704-2716

2018

Link zum Volltext

Verfügbarkeit prüfen

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol

The New England journal of medicine, 2017-04, Vol.376 (15), p.1430-1440

2017

Link zum Volltext

Verfügbarkeit prüfen

HDL-cholesterol, genetics, and coronary artery disease: the myth of the ‘good cholesterol’?

European heart journal, 2018-06, Vol.39 (23), p.2179-2182

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of oral anticoagulation on clinical outcomes of COVID-19: a nationwide cohort study of hospitalized patients in Germany

Clinical research in cardiology, 2021-07, Vol.110 (7), p.1041-1050

2021

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs in lipid metabolism and atherosclerosis

Best Practice & Research Clinical Endocrinology & Metabolism, 2016-10, Vol.30 (5), p.665-676

2016

Link zum Volltext

Verfügbarkeit prüfen

Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges

European heart journal, 2011-05, Vol.32 (10), p.1197-1206

2011

Link zum Volltext

Verfügbarkeit prüfen

2017 EACTS Guidelines on perioperative medication in adult cardiac surgery

European journal of cardio-thoracic surgery, 2018-01, Vol.53 (1), p.5-33

2018

Link zum Volltext

Verfügbarkeit prüfen

Into the Wild: GWAS Exploration of Non-coding RNAs

Frontiers in cardiovascular medicine, 2018-12, Vol.5, p.181-181

2018

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms of vascular effects of High‐density lipoprotein: alterations in cardiovascular disease

EMBO molecular medicine, 2012-04, Vol.4 (4), p.251-268

2012

Link zum Volltext

Verfügbarkeit prüfen

Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs

Arteriosclerosis, thrombosis, and vascular biology, 2013-06, Vol.33 (6), p.1392

2013

Link zum Volltext

Verfügbarkeit prüfen

Neurological update: use of cardiac troponin in patients with stroke

Journal of neurology, 2021-06, Vol.268 (6), p.2284-2292

2021

Link zum Volltext

Verfügbarkeit prüfen

High density lipoprotein - should we raise it?

Current vascular pharmacology, 2012-11, Vol.10 (6), p.718

Landmesser, Ulf

2012

Link zum Volltext

Verfügbarkeit prüfen

Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19

Nature biotechnology, 2021-06, Vol.39 (6), p.705-716

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of inclisiran, the small-interfering RNA against proprotein convertase subtilisin/kexin type 9, on platelets, immune cells, and immunological biomarkers: a pre-specified analysis from ORION-1

Cardiovascular research, 2021-01, Vol.117 (1), p.284-291

2021

Link zum Volltext

Verfügbarkeit prüfen

Xanthine Oxidase and Uric Acid in Cardiovascular Disease: Clinical Impact and Therapeutic Options

Seminars in nephrology, 2011-09, Vol.31 (5), p.433-440

2011

Link zum Volltext

Verfügbarkeit prüfen

Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure

European heart journal, 2016-06, Vol.37 (23), p.1789-1798

2016

Link zum Volltext

Verfügbarkeit prüfen

Maintaining Cardiovascular Health in the digital era

European heart journal, 2019-01, Vol.40 (1), p.9-12

2019

Link zum Volltext

Verfügbarkeit prüfen

AngiomiR-126 expression and secretion from circulating CD34+ and CD14+ PBMCs: role for proangiogenic effects and alterations in type 2 diabetics

Blood, 2013-01, Vol.121 (1), p.226-236

2013

Link zum Volltext

Verfügbarkeit prüfen

European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk

European heart journal, 2017-08, Vol.38 (29), p.2245-2255

2017

Link zum Volltext

Verfügbarkeit prüfen

Novel methodologies for biomarker discovery in atherosclerosis

European heart journal, 2015-10, Vol.36 (39), p.2635-2642

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 768

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(713)
Mit Volltextzugriff
(692)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(527)
Life Sciences & Biomedicine
(516)
Cardiovascular System & Cardiology
(390)
Humans
(375)
Cardiac & Cardiovascular Systems
(367)
Male
(168)
Female
(159)
Cardiology
(112)
Middle Aged
(110)
Aged
(101)
Treatment Outcome
(94)
Animals
(81)
Risk Factors
(73)
Medicine
(69)
Peripheral Vascular Disease
(68)
Cardiovascular Disease
(66)
Medicine & Public Health
(66)
Myocardial Infarction
(66)
Cardiology And Cardiovascular Medicine
(61)
Patients
(59)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Tissue factor as a link between inflammation and coagulation

Intestinal Microbiota in Cardiovascular Health and Disease

Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

HDL-cholesterol, genetics, and coronary artery disease: the myth of the ‘good cholesterol’?

Impact of oral anticoagulation on clinical outcomes of COVID-19: a nationwide cohort study of hospitalized patients in Germany

MicroRNAs in lipid metabolism and atherosclerosis

Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges

2017 EACTS Guidelines on perioperative medication in adult cardiac surgery

Into the Wild: GWAS Exploration of Non-coding RNAs

Molecular mechanisms of vascular effects of High‐density lipoprotein: alterations in cardiovascular disease

Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial

Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs

Neurological update: use of cardiac troponin in patients with stroke

High density lipoprotein - should we raise it?

Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19

Effect of inclisiran, the small-interfering RNA against proprotein convertase subtilisin/kexin type 9, on platelets, immune cells, and immunological biomarkers: a pre-specified analysis from ORION-1

Xanthine Oxidase and Uric Acid in Cardiovascular Disease: Clinical Impact and Therapeutic Options

Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure

Maintaining Cardiovascular Health in the digital era

AngiomiR-126 expression and secretion from circulating CD34+ and CD14+ PBMCs: role for proangiogenic effects and alterations in type 2 diabetics

European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk

Novel methodologies for biomarker discovery in atherosclerosis

Suchergebnisse filtern